315 related articles for article (PubMed ID: 16871532)
1. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
[TBL] [Abstract][Full Text] [Related]
2. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes.
Todd I; Radford PM; Daffa N; Bainbridge SE; Powell RJ; Tighe PJ
Arthritis Rheum; 2007 Aug; 56(8):2765-73. PubMed ID: 17665435
[TBL] [Abstract][Full Text] [Related]
3. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types.
Huggins ML; Radford PM; McIntosh RS; Bainbridge SE; Dickinson P; Draper-Morgan KA; Tighe PJ; Powell RJ; Todd I
Arthritis Rheum; 2004 Aug; 50(8):2651-9. PubMed ID: 15334481
[TBL] [Abstract][Full Text] [Related]
4. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
[TBL] [Abstract][Full Text] [Related]
5. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
[TBL] [Abstract][Full Text] [Related]
7. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
[TBL] [Abstract][Full Text] [Related]
8. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes.
Aganna E; Hammond L; Hawkins PN; Aldea A; McKee SA; van Amstel HK; Mischung C; Kusuhara K; Saulsbury FT; Lachmann HJ; Bybee A; McDermott EM; La Regina M; Arostegui JI; Campistol JM; Worthington S; High KP; Molloy MG; Baker N; Bidwell JL; Castañer JL; Whiteford ML; Janssens-Korpola PL; Manna R; Powell RJ; Woo P; Solis P; Minden K; Frenkel J; Yagüe J; Mirakian RM; Hitman GA; McDermott MF
Arthritis Rheum; 2003 Sep; 48(9):2632-44. PubMed ID: 13130484
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
[TBL] [Abstract][Full Text] [Related]
11. An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome.
Aganna E; Zeharia A; Hitman GA; Basel-Vanagaite L; Allotey RA; Booth DR; Hawkins PN; Thacker C; Syndercombe-Court D; McDermott MF
Arthritis Rheum; 2002 Jan; 46(1):245-9. PubMed ID: 11817598
[TBL] [Abstract][Full Text] [Related]
12. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.
D'Osualdo A; Ferlito F; Prigione I; Obici L; Meini A; Zulian F; Pontillo A; Corona F; Barcellona R; Di Duca M; Santamaria G; Traverso F; Picco P; Baldi M; Plebani A; Ravazzolo R; Ceccherini I; Martini A; Gattorno M
Arthritis Rheum; 2006 Mar; 54(3):998-1008. PubMed ID: 16508982
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
[TBL] [Abstract][Full Text] [Related]
14. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22.
Nakamura M; Tokura Y
Eur J Dermatol; 2010; 20(4):508-9. PubMed ID: 20400394
[No Abstract] [Full Text] [Related]
15. Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation.
Yousaf N; Gould DJ; Aganna E; Hammond L; Mirakian RM; Turner MD; Hitman GA; McDermott MF; Chernajovsky Y
Arthritis Rheum; 2005 Sep; 52(9):2906-16. PubMed ID: 16142754
[TBL] [Abstract][Full Text] [Related]
16. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution.
Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U
Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.
Nedjai B; Hitman GA; Quillinan N; Coughlan RJ; Church L; McDermott MF; Turner MD
Arthritis Rheum; 2009 Feb; 60(2):619-25. PubMed ID: 19180495
[TBL] [Abstract][Full Text] [Related]
18. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients.
Nakamura M; Kobayashi M; Tokura Y
Br J Dermatol; 2009 Oct; 161(4):968-70. PubMed ID: 19673872
[No Abstract] [Full Text] [Related]
19. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.
Dodé C; André M; Bienvenu T; Hausfater P; Pêcheux C; Bienvenu J; Lecron JC; Reinert P; Cattan D; Piette JC; Szajnert MF; Delpech M; Grateau G;
Arthritis Rheum; 2002 Aug; 46(8):2181-8. PubMed ID: 12209523
[TBL] [Abstract][Full Text] [Related]
20. "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis.
Kallinich T; Haffner D; Rudolph B; Schindler R; Canaan-Kühl S; Keitzer R; Burmester GR; Roesen-Wolff A; Roesler J
Ann Rheum Dis; 2006 Jul; 65(7):958-60. PubMed ID: 16308343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
